Close
Select up to 3 companies
Company |
ViAqua Therapeutics
|
|
|
|
---|---|---|---|---|
Short Description | Developer of RNA-based technology for feed additives to improve disease resistance in aquaculture stock |
|
|
|
Status | Private |
|
|
|
Year Founded | 2014 |
|
|
|
Industry Group | agriculture & food |
|
|
|
Sector | animals |
|
|
|
TRL Range | 4-6 |
|
|
|
Country | Israel |
|
|
|
Nbr Employees | 1-10 |
|
|
|
Revenue Range |
|
|
|
|
Total Equity Capital Raised |
$8.25M |
|
|
|
Last Stage Capital Raised |
Series A
round of
$8.25M
2023 |
|
|
|
Investors | Clay Capital, Nutreco, The Trendlines Group, S2G Investments, Rabo Ventures, Agriline, I-Lab Angels, Circle Investments |
|
|
|
Investment Data Information
Investment data is not editable by profile owners.
Please contact research@cleantech.com to make changes.
Close
Hey there!
We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!


We hope you've enjoyed an initial browse of i3. Select an option below to start enjoying i3's full capabilities!

Startups
Use i3 to gain visibility with corporations and investors looking to invest and partner with external technology companies.

Contact us
Use i3 to access market intelligence on companies, investors, market activity and innovation trends.
Are you involved with a startup or SME looking for strategic partners, investors, or customers? Create your free profile!
Contact us to discuss the full power of i3:
Close
Request Received!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Get in touch
We don't have team members for this company yet!
-
- Shai Ufaz
-
0 team members on i3
Work at this company?
Claim this profile
Traction
Similar companies
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
Sign up to see the full results!
You are viewing a limited version of this profile. To access i3's full capabilities. Sign up
Back to top